A Study of AG-80308 in Dry Eye Patients

NCT05372107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: AG-80308

Sponsor

Allgenesis Biotherapeutics Inc.

Collaborators

[object Object]